American Association for the Advancement of Science, Science Translational Medicine, 407(9), 2017
DOI: 10.1126/scitranslmed.aad4000
Full text: Unavailable
Inhibition of FABP4 rescues defective apelin signaling, decreases fatty acid accumulation, and promotes insulin sensitivity.